CMCO · Columbus McKinnon Corporation · Stock research

Current Thesis

The leg on offer is a levered-integration re-rating. Columbus McKinnon closed the $2.7B cash acquisition of Kito Crosby on 2026-02-03, and the quarter ended 2026-06-30 was the first full period as a combined company: net sales $531.5M (+125% YoY), orders $568.1M (+120% YoY), book-to-bill 1.1x, adjusted EBITDA $111.5M at a 21.0% margin (+720bps YoY). Management raised FY27 (year ending 2027-03-31) guidance on 2026-07-30 across all three lines — sales to $2.09–2.15B from $2.05–2.12B, adjusted EBITDA to $405–420M from $390–410M, adjusted EPS to $1.90–2.10 from $1.70–1.90 against a $1.75 consensus. What an investor is buying is the arithmetic of deleveraging: Credit Agreement Net Leverage of 4.9x at quarter-end against a stated path below 4x by FY28, funded by $70M of targeted annual run-rate synergies. Every turn of leverage retired transfers value from the debt stack to the equity stub. The corollary is that the equity is a spread trade on execution, priced off a $185–190M FY27 interest expense line that does not flex with demand.

Bullish and bearish views on Columbus McKinnon Corporation

The model's bull view on Columbus McKinnon Corporation (CMCO), in brief: The first combined print cleared the bar by a wide margin. The bear view: GAAP does not look like the adjusted deck. Both cases follow in full.

Bull Case

• The first combined print cleared the bar by a wide margin. Adjusted EPS $0.61 vs $0.27 consensus and sales $531.461M vs $501.262M consensus (2026-07-30). Adjusted net income $30.5M, +114% YoY.
• Demand is not the constraint right now. Orders of $568.1M exceeded sales of $531.5M for a 1.1x book-to-bill in the June quarter; legacy Columbus McKinnon net sales grew 12.7%, which CEO David Wilson attributed to U.S. short-cycle demand on the 2026-07-30 release.
• Margin is expanding on two engines at once. Adjusted gross margin 38.1% (+380bps YoY) and adjusted EBITDA margin 21.0% (+720bps YoY). CFO John Linker named the Kito Crosby mix, synergy realization and material-cost benefits as the drivers.
• The synergy target has room above it. Management signalled increasing confidence in exceeding the original $70M annual run-rate cost target, with Q1 capture weighted to SG&A — the manufacturing and procurement tranches are still ahead rather than spent.
• Guidance was raised on all three lines in one release, and the adjusted EPS guide is struck on stated assumptions of 52M adjusted diluted shares, $135–140M amortization, $75–80M depreciation and a 25% normalized tax rate (2026-07-30). Those assumptions are checkable at the next print.
• Sell-side is not uniformly positioned. J.P. Morgan (James Kirby) maintained Overweight and raised its target to $29 from $25 on 2026-07-31 — roughly 43% above the 2026-08-07 close of $20.22.

Bear Case

• GAAP does not look like the adjusted deck. The June quarter produced a GAAP net loss of $88.7M, or −$2.05 per diluted share, against $30.5M of adjusted net income. With $135–140M of FY27 amortization guided, the reported line stays impaired for years and screens built on GAAP earnings keep excluding the name.
• 4.9x is a real number. Credit Agreement Net Leverage of 4.9x at 2026-06-30 sits on $1.65B of Term Loan B, $900M of 7.125% senior secured notes due 2033 and a $500M revolver. The FY27 interest assumption of $185–190M is roughly 45% of the midpoint adjusted EBITDA guide.
• Cash conversion has not yet arrived. Q1 operating cash flow was $25.6M and free cash flow $20.0M ($32.4M excluding deal costs) against $111.5M of adjusted EBITDA. Deleveraging requires that gap to close over the balance of FY27.
• The preferred sits above the common. CD&R holds 800,000 Series A cumulative convertible participating preferred shares issued for $800.0M at a 7.0% dividend, converting at $37.68, plus three of twelve board seats (financing completed alongside the 2026-02-03 close). That dividend accrues ahead of the common regardless of how the operating year goes.
• The comparison base is engineered. Kito Crosby contributed $304.8M of the $531.5M in Q1, and the FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04, so YoY growth optics stay distorted through FY27.
• Coverage is dispersed rather than converged. Against J.P. Morgan's $29, DA Davidson (Matt Summerville) is carried at Neutral with an $18 target per a StreetInsider analyst-PT-change entry in the first week of August 2026 — below the 2026-08-07 close. Two firms reading the same print land roughly 60% apart on fair value.

Setup & Price Structure

On the pipeline's split- and dividend-adjusted basis as of 2026-08-07, the last completed daily close was $20.22, the 52-week high $23.01, and price sits 12.1% under that high after a +27.3% three-month return. RSI(14) reads 69.3.

That combination is what to sit with: momentum still reads hot while price has already surrendered a meaningful slice of the move off the high. INFERRED, not measured — with the 2026-07-30 guidance raise a handful of sessions back and a +27.3% quarter behind it, the $23.01 high most plausibly sits inside the post-earnings window, which makes the $20.22 close a giveback of the initial reaction rather than a base that has been tested.

Life-cycle: ACCELERATING. What dates it: the 2026-07-30 first-full-combined-quarter beat and guidance raise; the same-day cluster of Benzinga movers coverage (three separate pre-market and intraday industrial-mover items on 2026-07-30); the J.P. Morgan target raise to $29 on 2026-07-31. This is fresh attention on a company whose revenue base more than doubled six months ago and which most industrial screens have not re-underwritten. The counter-evidence against the label is the 12.1% distance from the high and an $18 Neutral target still standing after the print — flow moderated inside two weeks of the catalyst.

Crowding and positioning observables, stated as observables and not as a verdict: RSI(14) 69.3 with price 12.1% below the 52-week high; a +27.3% three-month advance; no company-scheduled catalyst inside the next 30 days beyond the annual meeting; a sell-side target range spanning $18 to $29 around a $20.22 close; an $800M private-equity preferred whose $37.68 conversion price sits far above spot. No insider transaction data appears in the filing feed for this window, so no claim is made in either direction on insider activity.

Catalyst Calendar (next 30 days)

• 2026-08-14 — 2026 Annual Meeting of Shareholders, held virtually at 9:00 a.m. ET per the company's proxy solicitation materials. Routine in expectation; the substantive item is the board as reconstituted at twelve directors including three CD&R designees.
• ~2026-09-01 (est.) — ISM Manufacturing PMI for August, released on the first business day of the month. Legacy Columbus McKinnon's 12.7% growth was explicitly tied to U.S. short-cycle demand; the new-orders sub-index is the cleanest public read on whether that persisted.
• Beyond the window: ~2026-10-29 (est.) — Q2 FY27 print. First opportunity to mark the 4.9x leverage ratio, the $70M synergy run-rate and the raised $2.09–2.15B sales guide against a second combined quarter. Nothing between now and then resolves the thesis.

What Would Change Our Mind

The structure that matters is the shelf built by the 2026-07-30 reaction, and it has not yet been retested. A daily close below $18.50 — roughly 20% under the $23.01 52-week high — would say the market handed back the guidance raise in full and that the +27.3% three-month advance was a re-rating that failed to hold. That is the gradeable break.

The fundamental break is separate and slower. At the Q2 FY27 print (~2026-10-29, est.), a Credit Agreement Net Leverage ratio printing above the 4.9x reported at 2026-06-30, a book-to-bill under 1.0x, or any trim to the $2.09–2.15B sales guide would each undercut the deleveraging arithmetic the equity is being paid for. Cutting the $70M run-rate synergy target, or pushing the sub-4x-by-FY28 leverage goal into FY29, does the same damage without touching the revenue line. In the other direction, free cash flow converting toward the $111.5M quarterly adjusted EBITDA run-rate would strengthen the case materially — Q1's $20.0M is the number to beat.

The passive failure mode is the 2026-08-14 annual meeting coming and going with no new disclosure and no fresh sell-side work, leaving roughly eleven weeks of empty calendar into late October. A name 12.1% off its high with RSI at 69.3 and no scheduled catalyst has to hold on flow alone.

Correlation Notes

• Interest-rate path feeds the P&L directly. The $1.65B Term Loan B is floating-rate; the $900M of 7.125% notes due 2033 is not. Front-end expectations move the $185–190M FY27 interest guide, the single largest claim on adjusted EBITDA.
• Short-cycle industrial complex. The demand signal is shared with Enerpac (EPAC), Kadant (KAI), Terex (TEX) and Manitowoc (MTW); order rates and book-to-bill matter more than reported revenue given backlog conversion lag.
• Small-cap levered beta. A capital structure at 4.9x behaves partly like credit — Russell 2000 drawdowns and high-yield spread widening transmit harder here than at an unlevered industrial of comparable size.
• Steel, chain and tariff inputs. "Benefits to material costs" was named as a Q1 margin driver on 2026-07-30; a reversal in steel or a tariff change on imported chain and rigging components pressures the 38.1% adjusted gross margin from the cost side.
• Private-equity overhang. CD&R's $800M preferred converts at $37.68 and pays 7.0%. Movement in the common toward that conversion price changes the effective share count the market underwrites — a sensitivity a plain-vanilla industrial does not carry.